At what price? A cost-effectiveness analysis comparing trial of labour after previous caesarean versus elective repeat caesarean delivery
Contribuinte(s) |
National Perinatal Epidemiology Centre, College of Medicine and Health, University College Cork |
---|---|
Data(s) |
01/10/2014
01/10/2014
06/03/2013
01/09/2014
|
Resumo |
Background: Elective repeat caesarean delivery (ERCD) rates have been increasing worldwide, thus prompting obstetric discourse on the risks and benefits for the mother and infant. Yet, these increasing rates also have major economic implications for the health care system. Given the dearth of information on the cost-effectiveness related to mode of delivery, the aim of this paper was to perform an economic evaluation on the costs and short-term maternal health consequences associated with a trial of labour after one previous caesarean delivery compared with ERCD for low risk women in Ireland.Methods: Using a decision analytic model, a cost-effectiveness analysis (CEA) was performed where the measure of health gain was quality-adjusted life years (QALYs) over a six-week time horizon. A review of international literature was conducted to derive representative estimates of adverse maternal health outcomes following a trial of labour after caesarean (TOLAC) and ERCD. Delivery/procedure costs derived from primary data collection and combined both "bottom-up" and "top-down" costing estimations.Results: Maternal morbidities emerged in twice as many cases in the TOLAC group than the ERCD group. However, a TOLAC was found to be the most-effective method of delivery because it was substantially less expensive than ERCD ((sic)1,835.06 versus (sic)4,039.87 per women, respectively), and QALYs were modestly higher (0.84 versus 0.70). Our findings were supported by probabilistic sensitivity analysis.Conclusions: Clinicians need to be well informed of the benefits and risks of TOLAC among low risk women. Ideally, clinician-patient discourse would address differences in length of hospital stay and postpartum recovery time. While it is premature advocate a policy of TOLAC across maternity units, the results of the study prompt further analysis and repeat iterations, encouraging future studies to synthesis previous research and new and relevant evidence under a single comprehensive decision model. Published Version Peer reviewed |
Formato |
application/pdf |
Identificador |
FAWSITT, C. G., BOURKE, J., GREENE, R. A., EVERARD, C. M., MURPHY, A. & LUTOMSKI, J. E. 2013. At What Price? A Cost-Effectiveness Analysis Comparing Trial of Labour after Previous Caesarean versus Elective Repeat Caesarean Delivery. PLoS ONE, 8, e58577. http://dx.doi.org/10.1371%2Fjournal.pone.0058577 8 3 e58577 1932-6203 http://hdl.handle.net/10468/1681 10.1371/journal.pone.0058577 Plos One |
Idioma(s) |
en |
Publicador |
Public Library of Science |
Direitos |
© 2013 Fawsitt et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. http://creativecommons.org/licenses/by/3.0/ |
Palavras-Chave | #Vaginal birth #Maternal morbidity #Caesarean section #Pregnancy #Cohort #Placenta accreta #Women #Outcomes #Pregnancies #Disease #Metaanalysis |
Tipo |
Article (peer-reviewed) |